Viewing Study NCT06866795

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:27 PM
Ignite Modification Date: 2026-01-29 @ 5:06 PM
Study NCT ID: NCT06866795
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-03-10
First Post: 2025-02-28
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase 1 Clinical Study of GT-220F in Subjects With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Sponsor: Geode Therapeutics Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Metastatic Castration Resistant Prostate Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prostate cancer View
None metastatic prostate cancer View
None castration resistant prostate cancer View
None PTEN-loss View
None mCRPC View
None PTEN-deficient View
None PI3K View
None PI3Kbeta View